Keratolytic Agents - Administration & dosage
Research News and Information

Tuesday, November 24, 2009

Benefits of using a hydroquinone/tretinoin skin care system in patients undergoing intense pulsed light therapy for photorejuvenation: a placebo-controlled study.

30 Aug 2009 A hydroquinone/tretinoin (HQ/tret) skin care system designed for use with non-surgical facial rejuvenation procedures has recently become available. In this observer-masked study, 36 patients with moderate-to-severe wrinkling of the skin around the ... Read more...

5-Fluorouracil superficial peel for multiple actinic keratoses.

30 Jul 2009 BACKGROUND: Chronically photodamaged skin usually presents with multiple, widespread, actinic keratoses (AKs), and treatment of the entire affected area is recommended. METHODS: We report our experience with a combination of Jessner's solution or ... Read more...

Traditional systemic treatment of psoriasis.

30 Jul 2009 Psoriasis is an inflammatory skin disease with a chronic relapsing course. In about 20%-30% of psoriatic patients, disease severity requires systemic treatment, which carries a huge economic and management burden for the healthcare system. The ... Read more...

Latest indexed articles for 'Keratolytic Agents - Administration & dosage'

These are the very latest articles for this heading:

• Benefits of using a hydroquinone/tretinoin skin care system in patients undergoing intense pulsed light therapy for photorejuvenation: a placebo-controlled study. 30 Aug 2009
• 5-Fluorouracil superficial peel for multiple actinic keratoses. 30 Jul 2009
• Traditional systemic treatment of psoriasis. 30 Jul 2009
• Effect of slow-releasing all-trans-retinoic acid in bioabsorbable polymer on delayed adjustable strabismus surgery in a rabbit model. 7 Jul 2009
• Palmoplantar pustulosis with arthro-osteitis: successful treatment with etanercept and acitretin. 29 Jun 2009
• Tretinoin microsphere gel pump 0.04% versus tazarotene cream 0.05% in the treatment of mild-to-moderate facial acne vulgaris. 29 Jun 2009
• A lipohydroxyacid-containing shampoo improves scalp condition and quality of life in patients with seborrheic dermatitis and light-to-moderate scalp psoriasis. 30 May 2009
• Efficacy, safety, and cost of Goeckerman therapy compared with biologics in the treatment of moderate to severe psoriasis. 30 May 2009
• The effects of topically applied glycolic acid and salicylic acid on ultraviolet radiation-induced erythema, DNA damage and sunburn cell formation in human skin. 30 Apr 2009
• Effect of Chinese herbal medicine combined with acitretin capsule in treating psoriasis of blood-heat syndrome type. 27 Apr 2009
• [Esthetic and corrective dermatology: clinical applications and social role] 20 Apr 2009
• [Topical treatments for psoriasis in 2009] 20 Apr 2009
• New drug information. Acanya. 30 Mar 2009
• Effectiveness, safety, and effect on quality of life of topical salicylic acid peels for treatment of postinflammatory hyperpigmentation in dark skin. 30 Mar 2009
• LCD plus NB-UVB reduces time to improvement of psoriasis vs. NB-UVB alone. 30 Mar 2009
• [Genital warts] 16 Mar 2009
• Mometasone furoate 0.1% and salicylic acid 5% vs. mometasone furoate 0.1% as sequential local therapy in psoriasis vulgaris. 9 Mar 2009
• Doxycycline-induced pseudotumor cerebri. 27 Feb 2009
• Detection of HPV-15 in painful subungual tumors of incontinentia pigmenti: successful topical therapy with retinoic acid. 10 Feb 2009
• Acne conglobata successfully treated by fractional laser after CO laser abrasion of cysts combined with topical tretinoin. 30 Jan 2009

See a longer list of these articles.

Technical information about 'Keratolytic Agents'

Definition: Agents that soften, separate, and cause desquamation of the cornified epithelium or horny layer of skin. They are used to expose mycelia of infecting fungi or to treat corns, warts, and certain other skin diseases.

Registry Number: 0

Descriptor UI: D007641

Alternative terms: Keratolytic Agents; Agents, Keratolytic; Skin-Peeling Agents; Agents, Skin-Peeling; Skin Peeling Agents; Desquamating Agents; Agents, Desquamating;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; antagonists & inhibitors; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;

Tree Number: D27.505.954.444.400;

Online Note: search DERMATOLOGIC AGENTS 1967-74

History Note: 91(75); was see under DERMATOLOGIC AGENTS 1975-90

Technical Notes: GEN or unspecified; prefer specifics